Close Menu

NEW YORK ─ Basel, Switzerland-based Roche said on Tuesday that it has received US Food and Drug Administration approval for use of its Cobas HIV-1/HIV-2 Qualitative Test on its fully automated real-time PCR-based Cobas 6800 and 8800 systems.

Roche's Cobas HIV-1/HIV-2 assay is a nucleic acid amplification test for the qualitative detection and differentiation of HIV-1 and HIV-2 RNA in human serum and plasma.  

The assay enables confirmatory HIV testing and HIV-1/HIV-2 differentiation in a single test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.